These ideas of yours definitely make sense @jwoody1000. My main concern with Novartis taking on our heart failure treatment along with ARDS would be that perhaps taking a larger position with Mesoblast would give them too much power? A proposal like this could be a double edged sword - great and financially wonderful in the short term but could lead to a certain loss of control for Mesoblast later on.
Ahh ... the suspense...
MSB Trading 2020 - a new dawn, page-12453
-
- There are more pages in this discussion • 618 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |